- Investing Ideas
- Japanese Pharmaceuticals & Biotech Bank Account Beaters
Japanese Pharmaceuticals & Biotech Bank Account Beaters
Results
6
Companies that are expected to sustainably pay a dividend that beats your savings account (over 3%).
6 companies
Takeda Pharmaceutical
Market Cap: JP¥8.6t
Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products.
4502
JP¥5,288.00
7D
-7.9%
1Y
25.5%
Daiichi Sankyo Company
Market Cap: JP¥4.7t
Manufactures and sells pharmaceutical products in Japan and internationally.
4568
JP¥2,505.00
7D
-13.3%
1Y
-29.8%
Astellas Pharma
Market Cap: JP¥3.9t
Engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally.
4503
JP¥2,168.50
7D
-2.9%
1Y
37.2%
Ono Pharmaceutical
Market Cap: JP¥1.1t
Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.
4528
JP¥2,297.50
7D
-4.9%
1Y
36.2%
Tsumura
Market Cap: JP¥282.5b
Engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally.
4540
JP¥3,759.00
7D
-4.3%
1Y
8.4%
Nippon Shinyaku
Market Cap: JP¥230.7b
Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.
4516
JP¥3,506.00
7D
-2.1%
1Y
6.3%